“…[30][31][32][33][34][35] In this regard, and as a continuation of our interest in the design and synthesis of novel asymmetric dyes [36][37][38][39][40][41][42] and antibody modification, we herein describe the development of a novel fluorescent cyanine dye. 37,43,44 The strengths of our novel asymmetric cyanine are as follows: first, we increased solubility by introducing a positively charged ionic core; second, we improved its photophysical properties, in particular increasing the Stokes shift by 25 nm, which improved image quality and reduced self-absorption, achieving an excitation maximum at the desirable 633 nm wavelength, and an improving photostability; and third, we added an azide-containing linker that enables its application in azide-alkyne click reactions, which results in an optimal fluorophore-antibody ratio. Thereafter we successfully cross-linked the candidate dye to the therapeutic antibody trastuzumab.…”